Admission to Trading

Summary by AI BETAClose X

Smith & Nephew plc has announced the admission to trading of 16,274 ordinary shares of USD 0.20 each on the London Stock Exchange's Main Market. These shares, identified by ISIN GB0009223206, are fully fungible with existing ordinary shares. The admission, which occurred between August 11 and September 7, 2026, relates to the company's employee share schemes and falls under existing block admissions. Following this issuance, the total number of ordinary shares in issue stands at 877,750,024, with 40,317,488 held in treasury.

Disclaimer*

Smith & Nephew Plc
18 September 2026
 

18 September 2026

Smith & Nephew plc

Admission to Trading

The following notification is made in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.

1

Details of the issuer

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

2

Details of the transferable securities admitted to trading

a)

Name

Smith & Nephew plc

b)

Type

Ordinary Shares of USD 0.20 each

c)

Identification code

ISIN: GB0009223206

d)

Regulated market

London Stock Exchange - Main Market

e)

Number of further securities issued and admitted

16,274

f)

Total number of securities in issue at date of notification

877,750,024 Ordinary Shares, of which 40,317,488 are held in treasury

g)

Fungibility

Fully fungible with existing Ordinary Shares

3

Admission details

a)

Date of admission

Admission of shares under the Company's employee share schemes from 11 August 2026 up to 7 September 2026, admitted to trading on the Main Market of the London Stock Exchange under the Company's existing block admission of shares dated 12 August 2022 and 2 July 2026.

b)

Prospectus details

N/A

 

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

Tel:    +44 (0)1923 477100

 

LEI:    213800ZTMDN8S67S1H61

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings